×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Christopher Gibson

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 04, 2025Conversion-60,000-973,839Dec 05, 2025, 07:20 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 04, 2025Gift-20,000-913,839Dec 05, 2025, 07:20 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 04, 2025Sale$4.6340,000185,200933,839Dec 05, 2025, 07:20 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 17, 2025Tax Payment (Shares)$4.1440,390167,215913,839Nov 19, 2025, 07:37 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 19, 2025Conversion-40,000-953,839Nov 19, 2025, 07:37 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 19, 2025Sale$4.1640,000166,400913,839Nov 19, 2025, 07:37 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 04, 2025Gift-20,000-954,229Nov 06, 2025, 04:23 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 04, 2025Sale$5.2140,000208,400974,229Nov 06, 2025, 04:23 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 04, 2025Conversion-60,000-1,014,229Nov 06, 2025, 04:23 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 23, 2025Conversion-100,000-1,054,229Oct 24, 2025, 06:49 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 23, 2025Sale$5.70100,000570,000954,229Oct 24, 2025, 06:49 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 10, 2025Gift-20,000-954,229Oct 10, 2025, 06:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 10, 2025Sale$6.04100,000604,000974,229Oct 10, 2025, 06:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 10, 2025Conversion-120,000-1,074,229Oct 10, 2025, 06:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 25, 2025Conversion-100,000-1,054,229Sep 26, 2025, 06:32 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 25, 2025Sale$4.76100,000476,000954,229Sep 26, 2025, 06:32 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 10, 2025Conversion-120,000-1,074,229Sep 12, 2025, 04:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 10, 2025Gift-20,000-954,229Sep 12, 2025, 04:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 10, 2025Sale$4.71100,000471,000974,229Sep 12, 2025, 04:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 26, 2025Conversion-100,000-1,054,229Aug 28, 2025, 08:00 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 26, 2025Sale$4.84100,000484,000954,229Aug 28, 2025, 08:00 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 15, 2025Tax Payment (Shares)$5.6440,390227,800954,229Aug 19, 2025, 06:22 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Conversion-100,000-100,000Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Conversion-423,666-1,504,919Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Sale$5.28100,000528,0000Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Gift-10,000-994,619Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Sale$5.28500,3002,641,5841,004,619Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Conversion-17,875-17,875Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 11, 2025Sale$5.2817,87594,3800Aug 13, 2025, 09:03 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 15, 2025Tax Payment (Shares)$4.2536,197153,8371,081,253May 19, 2025, 04:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 27, 2025Sale$6.04138,574836,9871,117,450Mar 28, 2025, 04:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 05, 2025Sale$6.5820,000131,6001,256,024Mar 07, 2025, 04:16 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 06, 2025Conversion-20,000-1,276,024Mar 07, 2025, 04:16 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 06, 2025Sale$6.3720,000127,4001,256,024Mar 07, 2025, 04:16 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 05, 2025Conversion-20,000-1,276,024Mar 07, 2025, 04:16 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 18, 2025Tax Payment (Shares)$10.6417,132182,2841,256,024Feb 20, 2025, 04:42 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 05, 2025Sale$7.6820,000153,6001,273,156Feb 07, 2025, 04:14 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 06, 2025Conversion-20,000-1,293,156Feb 07, 2025, 04:14 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 06, 2025Sale$8.1220,000162,4001,273,156Feb 07, 2025, 04:14 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 05, 2025Conversion-20,000-1,293,156Feb 07, 2025, 04:14 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerFeb 03, 2025Tax Payment (Shares)$7.255,56940,3751,273,156Feb 05, 2025, 04:50 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJan 08, 2025Conversion-20,000-756,633Jan 13, 2025, 05:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJan 08, 2025Sale$7.3120,000146,200736,633Jan 13, 2025, 05:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJan 10, 2025Conversion-20,000-756,633Jan 13, 2025, 05:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJan 10, 2025Sale$7.0520,000141,000736,633Jan 13, 2025, 05:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 04, 2024Conversion-20,000-756,633Dec 06, 2024, 05:46 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 04, 2024Sale$7.1620,000143,200736,633Dec 06, 2024, 05:46 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 05, 2024Conversion-20,000-756,633Dec 06, 2024, 05:46 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerDec 05, 2024Sale$7.1220,000142,400736,633Dec 06, 2024, 05:46 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 15, 2024Tax Payment (Shares)$6.1826,023160,692736,633Nov 19, 2024, 06:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 13, 2024Conversion-20,000-782,656Nov 15, 2024, 06:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 13, 2024Sale$7.7420,000154,800762,656Nov 15, 2024, 06:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 14, 2024Conversion-20,000-782,656Nov 15, 2024, 06:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerNov 14, 2024Sale$7.3520,000147,000762,656Nov 15, 2024, 06:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 03, 2024Sale$6.0820,000121,600762,656Oct 04, 2024, 06:30 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 02, 2024Conversion-20,000-782,656Oct 04, 2024, 06:30 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 02, 2024Sale$6.1620,000123,200762,656Oct 04, 2024, 06:30 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerOct 03, 2024Conversion-20,000-782,656Oct 04, 2024, 06:30 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 04, 2024Sale$6.0420,000120,800762,656Sep 06, 2024, 04:57 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 05, 2024Conversion-20,000-782,656Sep 06, 2024, 04:57 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 05, 2024Sale$6.1420,000122,800762,656Sep 06, 2024, 04:57 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerSep 04, 2024Conversion-20,000-782,656Sep 06, 2024, 04:57 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 30, 2024Option/RSU Exercise$2.485,00012,400762,656Aug 30, 2024, 04:26 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 29, 2024Option/RSU Exercise$2.485,00012,400757,656Aug 29, 2024, 04:22 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 28, 2024Option/RSU Exercise$2.485,00012,400752,656Aug 28, 2024, 04:12 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 27, 2024Option/RSU Exercise$2.485,00012,400747,656Aug 27, 2024, 04:10 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 26, 2024Option/RSU Exercise$2.485,00012,400742,656Aug 26, 2024, 04:42 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 23, 2024Option/RSU Exercise$2.485,00012,400737,656Aug 23, 2024, 05:25 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 15, 2024Tax Payment (Shares)$6.6926,082174,489732,656Aug 19, 2024, 07:09 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 08, 2024Conversion-20,000-778,738Aug 09, 2024, 04:56 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 08, 2024Sale$6.5020,000130,000758,738Aug 09, 2024, 04:56 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 07, 2024Conversion-30,000-788,738Aug 09, 2024, 04:56 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerAug 07, 2024Sale$7.1030,000213,000758,738Aug 09, 2024, 04:56 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJul 10, 2024Gift-25,000-758,738Jul 12, 2024, 06:54 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJul 10, 2024Sale$7.4850,000374,000758,738Jul 12, 2024, 06:54 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJul 11, 2024Conversion-50,000-808,738Jul 12, 2024, 06:54 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJul 11, 2024Sale$7.4750,000373,500758,738Jul 12, 2024, 06:54 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJul 10, 2024Conversion-50,000-808,738Jul 12, 2024, 06:54 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJun 05, 2024Conversion-100,000-908,738Jul 12, 2024, 06:52 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJun 05, 2024Sale$8.4250,000421,000758,738Jun 07, 2024, 04:01 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJun 06, 2024Sale$9.0050,000450,000708,738Jun 07, 2024, 04:01 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJun 05, 2024Conversion-25,000-833,738Jun 07, 2024, 04:01 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerJun 05, 2024Gift-25,000-808,738Jun 07, 2024, 04:01 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 15, 2024Tax Payment (Shares)$10.0126,082261,081808,738May 17, 2024, 07:11 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 01, 2024Sale$7.7350,000386,500863,524May 03, 2024, 06:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 02, 2024Conversion-21,296-856,116May 03, 2024, 06:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 02, 2024Sale$8.4750,000423,500834,820May 03, 2024, 06:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMay 01, 2024Gift-25,000-913,524May 03, 2024, 06:24 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 03, 2024Sale$8.8425,000221,0000Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 04, 2024Sale$9.0240,000360,800938,524Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 04, 2024Conversion-25,000-25,000Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 03, 2024Gift-25,000-1,018,524Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 04, 2024Sale$9.0225,000225,5000Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 03, 2024Sale$8.8440,000353,600978,524Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerApr 03, 2024Conversion-25,000-25,000Apr 05, 2024, 05:44 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 28, 2024Conversion-25,000-25,000Apr 01, 2024, 06:40 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 28, 2024Sale$10.1025,000252,5000Apr 01, 2024, 06:40 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 28, 2024Gift-25,000-1,083,524Apr 01, 2024, 06:40 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 28, 2024Sale$10.1040,000404,0001,043,524Apr 01, 2024, 06:40 PM
RXRXRECURSION PHARMACEUTICALS, INC.Christopher GibsonChief Executive OfficerMar 06, 2024Conversion-4,000-4,000Mar 08, 2024, 07:08 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe